Royalty Pharma Plc (RPRX) — Net Asset Quality Index
Royalty Pharma Plc (RPRX) has a Net Asset Quality Index of 50.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $19.82 Billion minus total liabilities of $9.88 Billion yields net assets of $9.94 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check RPRX asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Royalty Pharma Plc Net Asset Quality Index Over Time (2000–2025)
This chart shows how Royalty Pharma Plc's Net Asset Quality Index has evolved across 26 annual periods from 2000 to 2025. As of March 2026, the index stands at 50.1%, representing net assets of $9.94 Billion against total assets of $19.82 Billion USD. See how liquid is Royalty Pharma Plc's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Royalty Pharma Plc (2000–2025)
The table below presents the year-by-year Net Asset Quality Index for Royalty Pharma Plc from 2000 to 2025, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of Royalty Pharma Plc.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 49.5% | $9.71 Billion | $19.62 Billion | $9.91 Billion | ▼ -7.2 pp |
| 2024 | 56.8% | $10.34 Billion | $18.22 Billion | $7.88 Billion | ▼ -4.8 pp |
| 2023 | 61.6% | $10.08 Billion | $16.38 Billion | $6.30 Billion | ▲ +4.9 pp |
| 2022 | 56.7% | $9.53 Billion | $16.81 Billion | $7.29 Billion | ▼ -1.9 pp |
| 2021 | 58.5% | $10.25 Billion | $17.52 Billion | $7.27 Billion | ▼ -12.5 pp |
| 2020 | 71.0% | $14.97 Billion | $21.10 Billion | $6.12 Billion | ▲ +21.6 pp |
| 2019 | 49.3% | $6.14 Billion | $12.45 Billion | $6.31 Billion | ▲ +9.3 pp |
| 2018 | 40.0% | $4.55 Billion | $11.37 Billion | $6.82 Billion | ▲ +0.7 pp |
| 2017 | 39.3% | $4.47 Billion | $11.37 Billion | $6.90 Billion | ▼ -3.3 pp |
| 2016 | 42.5% | $4.46 Billion | $10.48 Billion | $6.02 Billion | ▼ -0.9 pp |
| 2015 | 43.4% | $4.70 Billion | $10.82 Billion | $6.12 Billion | ▼ -50.3 pp |
| 2014 | 93.8% | $44.02 Million | $46.94 Million | $2.92 Million | ▼ -1.7 pp |
| 2013 | 95.5% | $75.42 Million | $78.98 Million | $3.55 Million | ▲ +9.7 pp |
| 2012 | 85.8% | $23.03 Million | $26.83 Million | $3.80 Million | ▲ +8.9 pp |
| 2011 | 76.9% | $4.67 Million | $6.06 Million | $1.40 Million | ▲ +6.0 pp |
| 2010 | 70.9% | $3.17 Million | $4.46 Million | $1.30 Million | ▲ +51.9 pp |
| 2009 | 19.0% | $562.00K | $2.96 Million | $2.40 Million | ▼ -50.1 pp |
| 2008 | 69.1% | $15.61 Million | $22.60 Million | $6.99 Million | ▼ -18.1 pp |
| 2007 | 87.2% | $24.06 Million | $27.60 Million | $3.54 Million | ▲ +38.9 pp |
| 2006 | 48.3% | $3.79 Million | $7.85 Million | $4.06 Million | ▼ -47.6 pp |
| 2005 | 95.9% | $16.95 Million | $17.68 Million | $727.00K | ▲ +5.2 pp |
| 2004 | 90.7% | $5.99 Million | $6.61 Million | $614.00K | ▼ -7.0 pp |
| 2003 | 97.7% | $23.49 Million | $24.03 Million | $541.00K | ▼ -0.4 pp |
| 2002 | 98.1% | $26.85 Million | $27.37 Million | $519.00K | ▲ +15.3 pp |
| 2001 | 82.8% | $30.57 Million | $36.91 Million | $6.34 Million | ▲ +5.9 pp |
| 2000 | 76.9% | $31.06 Million | $40.37 Million | $9.31 Million | — |